DGCI gives permission to Bharat Biotech for manufacturing Covaxin

DGCI gives permission to Bharat Biotech for manufacturing Covaxin

The Drugs Controller General of India (DCGI) on Sunday gave licensing permission to Bharat Biotech to manufacture Covaxin, news agency ANI reported. Bharat Biotech has been asked to submit updated safety, efficacy and immunogenicity data from the ongoing Phase I, II and Ill clinical trials till the completion of trials, it further said.

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: